KORU MEDICAL SYSTEMS, INC. Financials KORU Medical Systems, Inc.
Equities
KRMD
US7599101026
Medical Equipment, Supplies & Distribution
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.19 USD | 0.00% |
|
+5.29% | -10.79% |
| Mar. 13 | Transcript : KORU Medical Systems, Inc., Q4 2023 Earnings Call, Mar 13, 2024 | |
| Mar. 13 | KORU Medical Systems, Inc. Enters into Loan and Security Agreement with HSBC Ventures USA Inc | CI |
Valuation
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Capitalization 1 | 257.9 | 264.5 | 133.7 | 161.6 | 112.1 | 102 | - | - |
| Enterprise Value (EV) 1 | 257.9 | 264.5 | 133.7 | 161.6 | 112.1 | 102 | 102 | 102 |
| P/E ratio | 653 x | -201 x | -30 x | -18.8 x | -8.18 x | -15.9 x | -31.3 x | 438 x |
| Yield | - | - | - | - | - | - | - | - |
| Capitalization / Revenue | 11.1 x | 10.9 x | 5.69 x | 5.79 x | 3.93 x | 3.23 x | 2.63 x | 2.15 x |
| EV / Revenue | 11.1 x | 10.9 x | 5.69 x | 5.79 x | 3.93 x | 3.23 x | 2.63 x | 2.15 x |
| EV / EBITDA | 45.9 x | 72.3 x | -75.3 x | -26.5 x | -18.6 x | -29.1 x | 99.4 x | 19.8 x |
| EV / FCF | - | - | - | - | - | - | - | - |
| FCF Yield | - | - | - | - | - | - | - | - |
| Price to Book | - | - | - | - | - | - | - | - |
| Nbr of stocks (in thousands) | 39,502 | 43,943 | 44,561 | 45,280 | 45,669 | 46,573 | - | - |
| Reference price 2 | 6.530 | 6.020 | 3.000 | 3.570 | 2.455 | 2.190 | 2.190 | 2.190 |
| Announcement Date | 2/25/20 | 3/23/21 | 3/2/22 | 3/8/23 | 3/13/24 | - | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 23.16 | 24.18 | 23.49 | 27.9 | 28.52 | 31.62 | 38.72 | 47.5 |
| EBITDA 1 | 5.615 | 3.661 | -1.775 | -6.096 | -6.03 | -3.506 | 1.026 | 5.142 |
| EBIT 1 | 0.5857 | 1.606 | -5.598 | -10.78 | -10.27 | -7.333 | -4.377 | -0.0715 |
| Operating Margin | 2.53% | 6.64% | -23.83% | -38.65% | -36.01% | -23.19% | -11.3% | -0.15% |
| Earnings before Tax (EBT) 1 | 0.6964 | -1.194 | -6.364 | -10.68 | -9.774 | -6.983 | -4.002 | -0.0715 |
| Net income 1 | 0.5644 | -1.212 | -4.563 | -8.661 | -13.74 | -6.19 | -3.494 | 0.0175 |
| Net margin | 2.44% | -5.01% | -19.42% | -31.05% | -48.18% | -19.58% | -9.02% | 0.04% |
| EPS 2 | 0.0100 | -0.0300 | -0.1000 | -0.1900 | -0.3000 | -0.1375 | -0.0700 | 0.005000 |
| Free Cash Flow | - | - | - | - | - | - | - | - |
| FCF margin | - | - | - | - | - | - | - | - |
| FCF Conversion (EBITDA) | - | - | - | - | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - | - | - | - |
| Announcement Date | 2/25/20 | 3/23/21 | 3/2/22 | 3/8/23 | 3/13/24 | - | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2021 Q3 | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 6.041 | 6.491 | 6.244 | 6.547 | 7.76 | 7.345 | 7.393 | 6.936 | 7.003 | 7.186 | 7.533 | 7.631 | 8.048 | 8.454 | 9.06 |
| EBITDA 1 | -0.5502 | -0.5853 | -1.854 | -2.367 | -0.3751 | -1.552 | -1.97 | -2.207 | -0.8903 | -0.9627 | -0.982 | -1.068 | -0.9123 | -0.544 | -0.097 |
| EBIT 1 | -1.287 | -2.111 | -2.794 | -3.293 | -1.529 | -2.511 | -3.008 | -3.218 | -1.791 | -2.198 | -1.888 | -1.986 | -1.908 | -1.552 | -1.477 |
| Operating Margin | -21.31% | -32.53% | -44.74% | -50.3% | -19.71% | -34.19% | -40.69% | -46.4% | -25.57% | -30.58% | -25.06% | -26.02% | -23.71% | -18.36% | -16.3% |
| Earnings before Tax (EBT) 1 | -1.332 | -1.444 | -3.135 | -3.632 | -1.497 | -2.411 | -2.988 | -3.096 | -1.669 | -2.021 | -1.812 | -1.886 | -1.808 | -1.477 | -1.427 |
| Net income 1 | -1.094 | -1.068 | -2.538 | -2.921 | -1.226 | -1.977 | -2.411 | -2.496 | -1.368 | -7.466 | -1.606 | -1.678 | -1.611 | -1.296 | -1.142 |
| Net margin | -18.11% | -16.46% | -40.64% | -44.62% | -15.79% | -26.91% | -32.61% | -35.98% | -19.54% | -103.9% | -21.31% | -21.98% | -20.02% | -15.32% | -12.6% |
| EPS 2 | -0.0200 | -0.0200 | -0.0600 | -0.0700 | -0.0300 | -0.0400 | -0.0500 | -0.0500 | -0.0300 | -0.1600 | -0.0350 | -0.0375 | -0.0350 | -0.0275 | -0.0200 |
| Dividend per Share | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Announcement Date | 11/10/21 | 3/2/22 | 5/4/22 | 8/3/22 | 11/9/22 | 3/8/23 | 5/4/23 | 8/9/23 | 11/8/23 | 3/13/24 | - | - | - | - | - |
1USD in Million2USD
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net Debt | - | - | - | - | - | - | - | - |
| Net Cash position | - | - | - | - | - | - | - | - |
| Leverage (Debt/EBITDA) | - | - | - | - | - | - | - | - |
| Free Cash Flow | - | - | - | - | - | - | - | - |
| ROE (net income / shareholders' equity) | - | - | - | - | - | - | - | - |
| ROA (Net income/ Total Assets) | - | - | - | - | - | - | - | - |
| Assets 1 | - | - | - | - | - | - | - | - |
| Book Value Per Share | - | - | - | - | - | - | - | - |
| Cash Flow per Share | - | - | - | - | - | - | - | - |
| Capex 1 | - | - | - | - | 0.78 | 0.9 | 1 | - |
| Capex / Sales | - | - | - | - | 2.75% | 2.85% | 2.58% | - |
| Announcement Date | 2/25/20 | 3/23/21 | 3/2/22 | 3/8/23 | 3/13/24 | - | - | - |
1USD in Million
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
C
Sell
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
2.19
USD
Average target price
3.375
USD
Spread / Average Target
+54.11%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -10.79% | 102M | |
| -2.31% | 187B | |
| -3.20% | 106B | |
| -5.04% | 66.9B | |
| +0.20% | 49.45B | |
| +17.29% | 48B | |
| +4.06% | 40.84B | |
| +2.36% | 26.25B | |
| +2.07% | 26.48B | |
| +12.96% | 24.62B |
- Stock Market
- Equities
- KRMD Stock
- Financials KORU Medical Systems, Inc.
